Using genetic test results to guide care during surgery
This study looks at whether using a person’s genetic information helps doctors make better decisions during planned surgery. It may help tailor care, but you would only join if you can consent and don’t have certain serious conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a planned elective surgery at the University of Chicago
- You are able to understand the study and sign informed consent
- You are not currently considering or planning liver or kidney transplant
- You do not have leukemia (active or past history)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to put genetic testing results (pharmacogenomics) into regular doctor care. It aims to see whether using the results helps doctors choose safer, better-matched medications.
This study uses personalized information to help understand how your current medicines interact with each other and with your genes. It may help your care team choose safer, more effective medication plans for you.
This study looks at whether knowing your genetic makeup can help doctors choose the safest and most effective pain medicine for you before you start taking opioids. If you are being treated for cancer and may need opioid pain medication soon, this trial might be a fit.
This study looks at whether genetic differences can help predict how much pain you may have after an elective (planned) operation. If you qualify, you may be asked to give consent and share information so researchers can compare pain experiences across people.
This study looks for genetic (DNA) clues that may help predict side effects or complications after heart surgery. If you join, your genome information may be used to understand who is at higher risk and why.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
Hear when a new Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.